Watch PHAT. Know when insiders buy.
One email the day a filing lands. Free.
PHAT
Phathom Pharmaceuticals, Inc.
5.25
+0.17 +3.35%
USD · close Nov 6
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
72
PASS · shorts 72
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $424.7MP/E —DIV YIELD —FCF YIELD -8.69%REV TTM $239.7M +110.2%NET INCOME −$99.1MNET CASH $17.9M52W 5.08 – 18.08SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose PHAT in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
James N. Topper and 16 related7.4%
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.